[go: up one dir, main page]

DE69029693D1 - Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz - Google Patents

Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz

Info

Publication number
DE69029693D1
DE69029693D1 DE69029693T DE69029693T DE69029693D1 DE 69029693 D1 DE69029693 D1 DE 69029693D1 DE 69029693 T DE69029693 T DE 69029693T DE 69029693 T DE69029693 T DE 69029693T DE 69029693 D1 DE69029693 D1 DE 69029693D1
Authority
DE
Germany
Prior art keywords
renal failure
hydantoin
imidazolidintrione
prevention
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029693T
Other languages
English (en)
Other versions
DE69029693T2 (de
Inventor
Hiroki Mikami
Kazuharu Ienaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69029693D1 publication Critical patent/DE69029693D1/de
Publication of DE69029693T2 publication Critical patent/DE69029693T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69029693T 1989-08-09 1990-08-07 Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz Expired - Fee Related DE69029693T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1207699A JP2678499B2 (ja) 1989-08-09 1989-08-09 尿毒症毒素低下剤

Publications (2)

Publication Number Publication Date
DE69029693D1 true DE69029693D1 (de) 1997-02-27
DE69029693T2 DE69029693T2 (de) 1997-05-07

Family

ID=16544105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029693T Expired - Fee Related DE69029693T2 (de) 1989-08-09 1990-08-07 Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz

Country Status (8)

Country Link
US (1) US5084473A (de)
EP (1) EP0412940B1 (de)
JP (1) JP2678499B2 (de)
KR (1) KR0151389B1 (de)
AT (1) ATE147625T1 (de)
DE (1) DE69029693T2 (de)
DK (1) DK0412940T3 (de)
ES (1) ES2095870T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) * 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
JP2004123736A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｒ）−ヒダントイン誘導体
JP2004123735A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｓ）−ヒダントイン誘導体
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
EP1961888A1 (de) * 2005-12-13 2008-08-27 Osamu Ito Kombinierte markisenvorrichtung und aufnahmerolle für leinwandflächengebilde
JP4660616B2 (ja) * 2009-08-31 2011-03-30 株式会社東芝 基板検査装置
JP6509729B2 (ja) * 2014-02-26 2019-05-08 日本臓器製薬株式会社 慢性腎臓病の進行抑制又は改善剤
US11464762B2 (en) 2017-06-13 2022-10-11 National Cancer Center Carcinogenesis inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS59199652A (ja) * 1983-04-27 1984-11-12 Kyowa Hakko Kogyo Co Ltd α−ケトカルボン酸塩類の製造方法
JPH0686436B2 (ja) * 1984-11-15 1994-11-02 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
JPH062748B2 (ja) * 1984-03-08 1994-01-12 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
JPH0764729B2 (ja) * 1985-02-06 1995-07-12 日本臓器製薬株式会社 イミダゾリジントリオン誘導体を含有する医薬組成物
ATE50248T1 (de) * 1985-02-06 1990-02-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
JPH0623102B2 (ja) * 1985-08-22 1994-03-30 日本臓器製薬株式会社 脂質低下剤
US4853401A (en) * 1987-04-01 1989-08-01 G. D. Searle & Co. Spiro-hydantoins as aldose reductase inhibitors
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤

Also Published As

Publication number Publication date
EP0412940A2 (de) 1991-02-13
DE69029693T2 (de) 1997-05-07
EP0412940A3 (en) 1991-10-23
US5084473A (en) 1992-01-28
JPH0372463A (ja) 1991-03-27
KR910004191A (ko) 1991-03-28
EP0412940B1 (de) 1997-01-15
JP2678499B2 (ja) 1997-11-17
DK0412940T3 (da) 1997-07-14
ATE147625T1 (de) 1997-02-15
ES2095870T3 (es) 1997-03-01
KR0151389B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
TW262461B (de)
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
OA09334A (fr) "Dérivés d'acides aminés".
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
DE68906609D1 (de) Dopamin-vorlaeufer.
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
NO923198L (no) Terapeutiske midler
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee